Advances in fragment-based drug discovery platforms

Area of Science:

• Drug Discovery
• Medicinal Chemistry

Background:

• Fragment-based drug discovery (FBDD) is a powerful alternative to high-throughput screening.
• FBDD is increasingly adopted by academic and industry drug discovery groups.
• Over 10 FBDD-derived compounds are in clinical development, highlighting its growing importance.

Purpose of the Study:

• To review recent advances in FBDD screening platforms.
• To discuss critical factors for successful FBDD.
• To explore the optimization of fragment exploitation in drug discovery.

Main Methods:

• Screening of fragment libraries (100-300 Da molecular mass) using various methods.
• Identification of weakly binding fragment hits.
• Utilizing fragment hits as starting points for potent drug lead generation.

Main Results:

• FBDD platforms continue to evolve with ongoing research and development.
• Optimization of screening and fragment exploitation is expected.
• The review synthesizes current progress in FBDD technologies.

Conclusions:

• Both initial fragment hit identification and subsequent lead generation are crucial in FBDD.
• Integration of diverse techniques (computational, biophysical, screening) is essential.
• Appropriate application of multiple methods ensures successful FBDD outcomes.